RNAi therapy mitigates preeclampsia symptoms in UMass Medical School study
A new study by Anastasia Khvorova, PhD, and Melissa Moore, PhD, at UMass Medical School and colleagues at Beth Israel Deaconess Medical Center and Western Sydney University, suggests that RNA interference therapy could be a potential strategy for the treatment of preeclampsia.Read more
Women in Science
Raziel Rojas-Rodriguez, a PhD candidate in the Program in Molecular Medicine, is studying how adipose tissue expansion during pregnancy is related to metabolic health. Learn more about her research in this Women in Science video.
Student AccomplishmentsRead more!
- RNAi therapy mitigates preeclampsia symptoms in UMass Medical School study
- Blu Genes Foundation gives UMMS $1.4M to bring Tay-Sachs gene therapy to clinical trial
- Robert Brown Jr. and Jonathan Watts honored by Angel Fund for ALS
- UMass Medical School scientists safely deliver RNAi-based gene therapy for ALS in animal model
- Silvia Corvera, Michael Czech receive $2.5M grant to advance potential therapy for type 2 diabetes
Student Interviews on LabTV
Find out what GSBS students are curious about! View Graduate Student LabTV Interviews.